FDB Moves Ambient Listening Beyond Notes with AI-Powered Prescribing Agent

First commercial deployment of FDB Script Agent™ with Tebra converts ambient encounter dialogue into structured prescriptions for clinician review, grounded in trusted medication intelligence

SOUTH SAN FRANCISCO, Calif., Aug. 24, 2026 /PRNewswire/ -- FDB (First Databank, Inc.), the leading provider of clinically robust, AI-enabled medication intelligence that helps healthcare professionals make precise medication decisions and streamline medication workflows, today announced the first commercial deployment of FDB Script Agent™, an AI prescribing agent that turns patient-visit dialogue into structured prescriptions ready for clinician review. The deployment with Tebra, an all-in-one technology platform for independent healthcare practices, brings FDB's trusted medication intelligence into the ambient clinical workflow with clinical validation and terminology codification rather than simple NLP.

Script Agent uses FDB's dose-appropriate medication intelligence to transform encounter dialogue into structured, evidence-based prescriptions for clinician review. Clinicians can modify or approve each prescription before it is sent. Due to its clinical grounding, the agent avoids hazards of simple NLP alone and will not stage prescriptions that fall outside normal prescribing practice without a clinician override.

Ambient AI has significantly reduced documentation burden by turning patient conversations into clinical notes, but prescribing often remains a manual task during or after the visit, and physician expectations are rising. FDB Script Agent extends ambient AI automation beyond documentation into prescribing by interpreting physician intent from the encounter and assembling the codified prescription elements needed by the EHR.

Tebra integrated Script Agent into its Tebra AI Note Assist, Tebra's AI-powered clinical documentation workflow for independent ambulatory practices.

"Prescribing is one of the most important moments in care, but it still buries clinicians in administrative work," said David Delaney, MD, president of FDB. "By capturing prescriptions directly from the ambient exam-room conversation and grounding them in FDB's trusted medication intelligence, Script Agent turns that dialogue into a structured prescription ready for review. This lowers the administrative burden of prescribing while keeping clinicians in control."

Early Tebra users report the AI Note Assist feature using Script Agent is intuitive and reduces prescribing-related administrative effort while preserving confidence in the review process.

"Independent practices are being asked to do more with fewer resources, and every minute spent on administrative work is time taken away from patient care," said Kyle Ryan, Tebra chief product and technology officer. "We're excited to partner with FDB to deliver AI-powered prescription review that simplifies prescribing workflows and reduces operational burden. These capabilities, as well as FDB's trusted, clinically validated content, drove our decision to collaborate and help advance Tebra's broader mission of equipping independent providers with advanced technology to make everyday healthcare operations more efficient and effective."

Script Agent also supports FDB's broader prescription intelligence strategy. Once a clinician approves a prescription, FDB Vela™, FDB's cloud-native ePrescribing network, can help carry it through the next steps of the medication journey, connecting prescribers, payers, pharmacies and patients.

The Tebra deployment of Script Agent marks the first step in FDB's broader roadmap for AI-powered prescription intelligence, designed to reduce administrative burden while keeping clinicians at the center of prescribing.

About FDB

FDB (First Databank) delivers clinically robust, AI-enabled and workflow-integrated medication intelligence that is intuitive, patient-specific, and actionable. Our solutions enable more precise medication decisions at the point of care. Trusted for our rigorous quality control, deep clinical expertise, and collaborative approach, we help improve patient safety, streamline medication workflow operations, and enhance health outcomes. Our comprehensive medication intelligence and next-generation medication decision support solutions power healthcare information systems used by the majority of hospitals, physician practices, pharmacies, payers, and beyond, impacting millions of clinicians, business associates, and patients every day. For a complete look at FDB's solutions and services, please visit https://www.fdbhealth.com, or follow us on LinkedIn and YouTube.

About Hearst Health

The mission of Hearst Health is to guide healthcare organizations by delivering essential intelligence and software that improve the quality, safety and efficiency of care. Hearst Health has been innovating with care for more than 40 years, with a commitment to making a lasting positive impact on health. The Hearst Health companies, FDB, Homecare Homebase, MCG, MHK, QGenda and Zynx Health, elevate care by informing and empowering participants across the health journey. To learn more, visit https://www.hearst.com/hearst-health and follow @Hearst Health on LinkedIn.

About Tebra

Tebra is the only all-in-one EHR+ platform built exclusively for independent healthcare practices. Designed to replace the clunky, fragmented tools built for corporate systems, Tebra connects EHR software, billing, automation, telehealth solutions, and marketing — so providers can spend less time on admin and more time with patients. More than 42,000 private practices trust Tebra to streamline operations, increase revenue, and reduce burnout — helping clinicians leave work on time and rediscover their purpose. Learn more at www.tebra.com.

Media Contact

Supreme Communications for FDB

[email protected]

SOURCE FDB (First Databank)